Kramer Caroline K, Camargo Joíza, Ricardo Eliza D, Almeida Fernando K, Canani Luís H, Gross Jorge L, Azevedo Mirela J
Endocrine Division, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Brazil.
Nephrol Dial Transplant. 2009 Apr;24(4):1193-6. doi: 10.1093/ndt/gfn629. Epub 2008 Nov 17.
Urinary albumin is the main parameter employed to diagnose diabetic nephropathy (DN). The exclusion of bacteriuria has been recommended at the time of DN diagnosis. This approach has been debated and information on this suggestion in patients with diabetes is scarce. The present case-control study was conducted to investigate the interference of bacteriuria in the interpretation of urinary albumin measurements in random urine samples of diabetic patients.
Urinary albumin concentration (UAC) was measured in random urine samples twice in diabetic patients with and without bacteriuria (> or =10(5) colony-forming units/mL). Cases (n = 81) were defined as patients who had baseline UAC measurement in the presence of bacteriuria and had the second UAC measured in a sterile urine sample. Controls (n = 80) had the two UAC measured in sterile urine specimens.
Baseline UAC was not different between case [15.4 (1.5-2148) mg/L] and control groups [14.2 (1.5-1292) mg/L; P = 0.24], nor was the proportion of patients with normo-, micro- and macroalbuminuria. In cases, UAC measurements in the presence of bacteriuria and in sterile urine specimens were not different [15.4 (1.5-2148) versus 13.7 (1.5-2968) mg/L; P = 0.14)], nor was the proportion of normo- (51.9% versus 61.5%), micro- (40.7% versus 32.1%) and macroalbuminuria (7.4% versus 6.4%; P = 0.46). In the control group, UAC values were also not different in the two urine samples: [14.2 (1.5-1292) versus 9.7 (1.5-1049) mg/L, P = 0.22].
The presence of bacteriuria does not interfere significantly with urinary albumin measurements and its exclusion is not necessary to diagnose DN.
尿白蛋白是诊断糖尿病肾病(DN)的主要参数。在诊断DN时,建议排除菌尿。这种方法一直存在争议,且关于糖尿病患者这一建议的信息很少。本病例对照研究旨在调查菌尿对糖尿病患者随机尿样中尿白蛋白测量结果解读的干扰。
对有菌尿(≥10⁵菌落形成单位/毫升)和无菌尿的糖尿病患者的随机尿样进行两次尿白蛋白浓度(UAC)测量。病例组(n = 81)定义为在有菌尿时进行基线UAC测量且在无菌尿样中进行第二次UAC测量的患者。对照组(n = 80)在无菌尿标本中进行两次UAC测量。
病例组[15.4(1.5 - 2148)毫克/升]和对照组[14.2(1.5 - 1292)毫克/升;P = 0.24]的基线UAC无差异,正常白蛋白尿、微量白蛋白尿和大量白蛋白尿患者的比例也无差异。在病例组中,有菌尿时和无菌尿样中的UAC测量结果无差异[15.4(1.5 - 2148)对13.7(1.5 - 2968)毫克/升;P = 0.14],正常白蛋白尿(51.9%对61.5%)、微量白蛋白尿(40.7%对32.1%)和大量白蛋白尿(7.4%对6.4%;P = 0.46)的比例也无差异。在对照组中,两个尿样的UAC值也无差异:[14.2(1.5 - 1292)对9.7(1.5 - 1049)毫克/升,P = 0.22]。
菌尿的存在对尿白蛋白测量无显著干扰,诊断DN时无需排除菌尿。